Acorai receives Breakthrough Device Designation for their non-invasive intracardiac pressure monitor

/PRNewswire/ -- Acorai, a start-up medical device manufacturer from Sweden, today announces that the U.S. Food and Drug Administration (FDA) has granted...

Related Keywords

Sweden ,Helsingborg ,Skane Lan ,Swedish ,Jakob Gelberg ,Kasper Bourdette ,Andrewj Sauer ,Abbott Astrazeneca ,Filip Peters ,Drug Administration ,Ge Healthcare ,Breakthrough Device Designation ,Heart Monitor ,Stagec Heart Failure ,Breakthrough Device ,Co Founder Filip Peters ,Chief Operating Officer ,Chief Technology Officer ,Chief Scientific Officer ,New Standard ,Heart Failure Management ,Chief Clinical Advisor ,Life Science Invest ,Golden Angel Investors ,Acorai Intracardiac Monitoring System ,Acorai Ab ,Computer Amp Electronics ,Health Care Amp Hospitals ,Medical Pharmaceuticals ,Medical Equipment ,Fda Approval ,Clinical Trials Amp Medical Discoveries ,